Diagnostic workup led to diagnosis of T4N3M1b squamous cell carcinoma (SCC), epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations negative. This evidence concerns the gene ALK and squamous cell carcinoma.